<DOC>
	<DOCNO>NCT00993915</DOCNO>
	<brief_summary>In CHD patient high risk CV complication different dos LIPRIMAR use ? For purpose , data hyperlipidemia elicit basic nosographic demographic data , concomitant disease cardiovascular risk factor .</brief_summary>
	<brief_title>Study On Liprimar ( Atorvastatin ) In Patients With Coronary Heart Disease ( CHD ) And High Risk Of Cardiovascular Complications</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Patients , eligible sign inform consent ; Patients indication lipid low therapy , accord local product document . Patients CHD high risk CV complication ( Diabetes Mellitus II , Myocardial Infarction , Heart Failure , Arterial Hypertension , ets ) include study ; Patients LDL level : &gt; 3,5 mmol/l Individual intolerance atorvastatin , accordance local product document .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Hyperlipidemia</keyword>
	<keyword>Atorvastatin</keyword>
</DOC>